Compugen | CGEN - Srodki Pieniężne I Ekwiwalent





Srodki Pieniężne I Ekwiwalent Zmiana Data
Arca Biopharma USD 49.52M 2.58M 2026-03
aTyr Pharma USD 10.01M 735K 2026-03
Bio Path 13.65M 3.37M 2022-09
Brainstorm Cell Therapeutics USD 15K 14K 2026-03
Cara Therapeutics USD 20.73M 684K 2025-12
Clal Biotechnology ILS 5.73M 1.71M 2023-12
Compugen USD 12.43M 78.16M 2026-03
Immunic USD 186.63M 171.15M 2026-03
Minerva Neurosciences USD 82.3M 70.02M 2025-12
RedHill Biopharma USD 2.87M 1.75M 2025-06
TherapeuticsMD 523K 89K 2024-06